Malaria Vaccine Passes Key Regulatory Hurdle

An anonymous reader writes: The BBC reports that the European Medicines Agency has approved the world's first malaria vaccine for real-world use. The vaccine is far from perfect, and the World Health Organization still has to make a final decision on it, but it's a key victory for GlaxoSmithKline, who have been developing the vaccine for three decades. "The best protection was among children aged five to 17 months who received three doses of the vaccine a month apart, plus a booster dose at 20 months. In this group, cases of severe malaria were cut by a third over four years." Unfortunately, the boosters are quite necessary for protection, and it doesn't protect young babies from malaria. The disease "kills around 584,000 people a year worldwide, most of them children under five in sub-Saharan Africa."

Comments

Surprised it could be done

[Anonymous Coward]

Malaria in humans is caused by five different species of plasmodium parasites. That they could get a vaccination at all effective is wonderful and surprising.